COPD in primary lung cancer patients: prevalence and mortality

Results are presented for various cancer risks: cancer mortality, overall cancer risk and cancer risks for the most common cancer sites, including colorectal cancer, lung cancer,

MicroRNAs are differentially expressed between rectal cancer patients diagnosed with metastatic disease (stage IV) compared to non-metastatic patients (stage I-III). A)

Conclusions: Cytokine serum levels vary and correlate with metabolic tumor burden in patients with advanced non-small cell lung cancer undergoing palliative thoracic radiation

"Although the adverse effects of beta-carotene on human lung cancer risk have only been observed in groups at elevated risk for lung cancer, the studies available with cohorts at

Rationale: There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without

The fi ve cancer types most frequently mentioned in our study (breast, hematologic, lung, skin and colorectal cancer) were also found to be among the cancers with the highest

The main finding of this study on subjects with COPD followed for ten years was that AECOPD was only significantly associated with increased risk of lung cancer in COPD patients

The data included all Norwegian patients aged 18 years and above in CPPs for lung, colorectal, prostate or breast cancer (CPP patients) and patients diagnosed with lung,